Bringing the fundamentals into focus…
Back to Ironwood Pharmaceuticals, Inc.
How Ironwood Pharmaceuticals, Inc. stacks up
IRWD · against 454 other Healthcare companies listed in US-listed
Growth
81/ 100
Above the middle of the pack.
Ranked #138 of 455 · scores higher than 69% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including IRWD · Click a bar to see the companies
Why growth scores 81?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
- slower revenue growth over three years: weaker than 78% of peers. 3-year revenue growth: -3.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 84% of peers. Revenue growth: 26.2% vs peer median 6.1%
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = IRWD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IRWD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 26.2% | 11.0% | 72% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 1400.0% | 21.2% | 97% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | -3.1% | 11.0% | 14% | 33% |
Ranking by growth score
Top 5 and the companies ranked around IRWD| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 131 | 6.0B USD | 82 | 30 | |
| 131 | 23.8B USD | 82 | 84 | |
| 131 | 4.4B USD | 82 | 66 | |
| 131 | 2.7B USD | 82 | 44 | |
| 138 | 578M USD | 81 | 73 | |
| 138 | 650M USD | 81 | 48 | |
| 138 | 423M USD | 81 | 29 | |
| 138 | 124M USD | 81 | 31 | |
| 138 | 1.5B USD | 81 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score